Royal Philips Sees Positive Results From InCourage System Study
23 Luglio 2020 - 03:46PM
Dow Jones News
By Adriano Marchese
Koninklijke Philips NV said Thursday that a study of its
InCourage system found positive results, with lower rates of
hospitalization and antibiotic use in patients with chronic
respiratory issues.
The Dutch medical-technology company said the peer-reviewed
study of airway clearance use for bronchiectasis monitored 2,596
patients receiving high frequency chest wall oscillation therapy
using the InCourage system for one year.
The study found that in the first year of use, the rate of
hospitalization dropped 54.5%, self-reported ability to clear lungs
improved to 76.6% from 13.9% and antibiotic use fell to 29.9% from
57.7%, the company said.
Write to Adriano Marchese at adriano.marchese@wsj.com
(END) Dow Jones Newswires
July 23, 2020 09:31 ET (13:31 GMT)
Copyright (c) 2020 Dow Jones & Company, Inc.
Grafico Azioni Koninklijke Philips NV (EU:PHIA)
Storico
Da Feb 2024 a Mar 2024
Grafico Azioni Koninklijke Philips NV (EU:PHIA)
Storico
Da Mar 2023 a Mar 2024